A ample of the serum pool contining the MS-1 agent was found negative when examined by immunodiffusion, complement fixation, and electron microscopy. The possible lack of immunological identity between infectious and serum hepatitis discussed.
Introduction
The close association between the Australia-SH antigen and serum hepatitis is now established (Zuckerman, 1969a) , but the immunological relation between infectious hepatitis and serum hepatitis is' far less clear. Giles et al. (1969) demonstrated in human volunteers a distinct difference between infections with the MS-1 agent (infectious hepatitis variety) and MS-2 (serum hepatitis long-incubation type of infection). They found that the Australia-SH antigen was present in all volunteers infected with MS-2, whereas this antigen was not detected in any of the serial serum specimens collected from volunteers infected with MS-1. This remarkably consistent association between the Australia-SH antigen and MS-2 infection, the high frequency of persistent carriage of the agent in blood, and failure to detect the Australia-SH antigen in infectious hepatitis and infection with MS-1 (Prince, 1968; Giles et al., 1969; Zuckerman and Taylor, un- published observations) must imply either that there are immunological differences between the two infecting agents or that the available tests are not sensitive enough to detect the latter. Furthermore, the well-recognized effect of human immunoglobulin in attenuating infectious hepatitis and its almost consistent failure to influence the course of posttransfusion hepatitis (Hepatitis Surveillance Reports, 1968) support the view of lack of immunological identity between the Australia antigen and infectious hepatitis virus. On the other hand, a number of investigators (Blumberg et al., 1969; Gocke et al., 1969; Gocke and Kavey, 1969) The Australia-SH antigen has also been found in a small proportion of patients with chronic active hepatitis (Gitnick et al., 1969; Fox et al., 1969; Wright et al., 1969 Sever (1962) except that the serum was examined for the presence of antigen.
For examination by electron microscopy 0-5 ml. of serum was diluted to 2 ml. with phosphate-buffered saline and centrifuged for one hour at 18,000 r.p.m. in rotor 425 of the Sorvall RC2B centrifuge. The supernatant was discarded and the pellet resuspended to the original volume in phosphatebuffered saline. This suspension was centrifuged as before and the pellet so obtained was used for electron microscopy (Al- tinct virus-like structures was noted. The morphological characteristics of these particles were typical of a member of the coronavirus group (Almeida et al., 1968) (Figs. 2, 3 , and 4). Though obviously displaying the characteristics of the coronavirus group, all of the particles obtained were in association with antibody, and the appearance of coronavirus complexed with antibody is now well known (Fig. 6) . The complementfixing antibody titre to mouse hepatitis virus 3, kindly measured by Mr. A. Bradburne, was 1:640. On the other hand, serum containing the MS-1 agent proved negative by all three tests-namely, immunodiffusion, complement fixation, and electron microscopy.
Discussion
It is well known that viruses which do not normally produce liver damage with jaundice may on occasion display increased hepatotropism, producing a clinical picture which is similar to hepatitis (Zuckerman, 1969b) . This group includes a wide variety of viruses, such as herpesvirus, paramyxoviruses, rubella virus. enteroviruses, reovirus, and others.
The virus morphology that we found associated with serum 697 is of considerable interest inasmuch that mouse hepatitis virus (Fig. 5 ) is known to belong to the same coronavirus group. So far other members of this group have been respiratory in type-for example, avian infectious bronchitis virus and a number of common cold human serotypes. It is of interest that a human serum should contain a coronavirus, seemingly associated with hepatitis, when a similar relationship has been shown in the mouse. Hartley et al. (1964) found neutralizing antibodies, which reacted with mouse hepatitis virus, in many human sera. Similarly, complement-fixing antibodies were found by Pollard and Bussell (1957) . Two distinct possibilities may explain the presence of antibodies in man to mouse hepatitis virus. The antibody response may be due to contact with mouse faeces or to a hitherto undescribed human virus which is generically related to the mouse hepatitis viruses. The first possibility seems unlikely because the incidence of antibody to mouse hepatitis among laboratory workers is no higher than in control groups. The second alternative must therefore be seriously entertained-that is, that the particles we describe here are a human counterpart to the mouse hepatitis virus and may well show serological relationship to it. The role of the coronaviruses in infectious hepatitis should therefore be examined further.
The negative findings with the MS-1 pool support the observations of Giles et al. (1969) 
